$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
达沙替尼在肝、肾损伤的患者中需要修改剂量吗?
2025-10-19 11:44:20
Check Details
普纳替尼(Ponatinib)说明书
2025-10-19 11:44:20
Check Details
服用达沙替尼QT间期如何变化
2025-10-19 11:44:20
Check Details
达沙替尼的药效能维持多久
2025-10-19 11:44:20
Check Details
达沙替尼服用期间的注意事项
2025-10-19 11:44:20
Check Details
达沙替尼的疗效分析
2025-10-19 11:44:20
Check Details
达沙替尼对白血病有没有作用
2025-10-19 11:44:20
Check Details
达沙替尼服用过量之后有什么需要注意的地方
2025-10-19 11:44:20
Check Details
达沙替尼在具有局部器官损伤时如何调整剂量?
2025-10-19 11:44:20
Check Details
达沙替尼片注意事项
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病的安全性如何
2025-10-19 11:44:20
Check Details
达沙替尼治疗白血病的效果怎么样
2025-10-19 11:44:20
Check Details
1
2
...
144
145
146
147
148
149
150
...
940
941
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Selinexor: Dosing, Food, and Safety
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Key points for drug monitoring of Molotinib in bone marrow fibrosis
5
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
6
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
7
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
8
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
9
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
10
Revumenib: Key Considerations Before and During Treatment
11
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
12
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use